ACTA2 and lung adenocarcinoma: Several studies have reported the function of ACTA2-AS1, enhancing the malignant phenotype of cervical cancer (Luo et al., 2020), while exhibiting anti-tumor effects in liver cancer (Zhou and Lv, 2019), and lung adenocarcinoma (Ying et al., 2020).